| Mrs Kelly Elizabeth Mistry, MD | |
|
2637 Midpoint Dr Ste B, Fort Collins, CO 80525-4408 | |
| (434) 243-4394 | |
| (434) 243-4873 |
| Full Name | Mrs Kelly Elizabeth Mistry |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 17 Years |
| Location | 2637 Midpoint Dr Ste B, Fort Collins, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487858346 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 0101244716 (Virginia) | Secondary |
| 208M00000X | Hospitalist | DR.0049829 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical Center Of The Rockies | Loveland, CO | Hospital |
| Poudre Valley Hospital | Fort collins, CO | Hospital |
| Uchealth Greeley Hospital | Greeley, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Colorado Hospitalists Professional Llc | 8325147507 | 68 |
News Archive
QLT Inc. welcomed the 6-month results from the Novartis-sponsored EVEREST study which were presented during a scientific review today by Novartis in Basel, Switzerland.
Seizures are a common result of traumatic brain injury, especially in military veterans. A new study funded by the DOD, Congressionally Directed Medical Research Programs, and conducted in Providence RI and Birmingham AL hopes to shed new light on the mechanism behind seizures associated with post-traumatic epilepsy and psychogenic nonepileptic seizures.
News organizations track developments in California, Minnesota, North Carolina and Wisconsin as state online insurance marketplaces gear up for the second open enrollment season.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has signed a definitive asset purchase agreement to sell its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional $20 million in royalties.
› Verified 2 days ago
| Entity Name | Colorado West Healthcare System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497723407 PECOS PAC ID: 3971491887 Enrollment ID: O20040310000712 |
News Archive
QLT Inc. welcomed the 6-month results from the Novartis-sponsored EVEREST study which were presented during a scientific review today by Novartis in Basel, Switzerland.
Seizures are a common result of traumatic brain injury, especially in military veterans. A new study funded by the DOD, Congressionally Directed Medical Research Programs, and conducted in Providence RI and Birmingham AL hopes to shed new light on the mechanism behind seizures associated with post-traumatic epilepsy and psychogenic nonepileptic seizures.
News organizations track developments in California, Minnesota, North Carolina and Wisconsin as state online insurance marketplaces gear up for the second open enrollment season.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has signed a definitive asset purchase agreement to sell its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional $20 million in royalties.
› Verified 2 days ago
| Entity Name | Pathways Hospice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063444305 PECOS PAC ID: 7911914577 Enrollment ID: O20060307000795 |
News Archive
QLT Inc. welcomed the 6-month results from the Novartis-sponsored EVEREST study which were presented during a scientific review today by Novartis in Basel, Switzerland.
Seizures are a common result of traumatic brain injury, especially in military veterans. A new study funded by the DOD, Congressionally Directed Medical Research Programs, and conducted in Providence RI and Birmingham AL hopes to shed new light on the mechanism behind seizures associated with post-traumatic epilepsy and psychogenic nonepileptic seizures.
News organizations track developments in California, Minnesota, North Carolina and Wisconsin as state online insurance marketplaces gear up for the second open enrollment season.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has signed a definitive asset purchase agreement to sell its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional $20 million in royalties.
› Verified 2 days ago
| Entity Name | Northern Colorado Hospitalists Professional Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831315662 PECOS PAC ID: 8325147507 Enrollment ID: O20070628000638 |
News Archive
QLT Inc. welcomed the 6-month results from the Novartis-sponsored EVEREST study which were presented during a scientific review today by Novartis in Basel, Switzerland.
Seizures are a common result of traumatic brain injury, especially in military veterans. A new study funded by the DOD, Congressionally Directed Medical Research Programs, and conducted in Providence RI and Birmingham AL hopes to shed new light on the mechanism behind seizures associated with post-traumatic epilepsy and psychogenic nonepileptic seizures.
News organizations track developments in California, Minnesota, North Carolina and Wisconsin as state online insurance marketplaces gear up for the second open enrollment season.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has signed a definitive asset purchase agreement to sell its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional $20 million in royalties.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kelly Elizabeth Mistry, MD 2637 Midpoint Dr Ste B, Fort Collins, CO 80525-4408 Ph: (970) 488-1666 | Mrs Kelly Elizabeth Mistry, MD 2637 Midpoint Dr Ste B, Fort Collins, CO 80525-4408 Ph: (434) 243-4394 |
News Archive
QLT Inc. welcomed the 6-month results from the Novartis-sponsored EVEREST study which were presented during a scientific review today by Novartis in Basel, Switzerland.
Seizures are a common result of traumatic brain injury, especially in military veterans. A new study funded by the DOD, Congressionally Directed Medical Research Programs, and conducted in Providence RI and Birmingham AL hopes to shed new light on the mechanism behind seizures associated with post-traumatic epilepsy and psychogenic nonepileptic seizures.
News organizations track developments in California, Minnesota, North Carolina and Wisconsin as state online insurance marketplaces gear up for the second open enrollment season.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has signed a definitive asset purchase agreement to sell its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional $20 million in royalties.
› Verified 2 days ago
Dr. Jennifer Levy Woelk, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 | |
Victoria Anne Clipsham, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 | |
Dr. Nancy Terrell Maller, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 | |
Dr. Rebecca Rain Jackson, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1032 Luke St Ste 1, Fort Collins, CO 80524 Phone: 970-568-5810 | |
Eduardo Cruz Pareja, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr, Fort Collins, CO 80525 Phone: 970-488-1666 | |
Dr. Nathan Michael Smith, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 |